日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study

奇格列他扎治疗伴有高甘油三酯血症和胰岛素抵抗的MASLD:一项II期随机、双盲、安慰剂对照研究

Sun, Yameng; Wu, Cuisong; Xin, Guijie; Zhong, Bihui; Wu, Xiaofeng; Liu, Yali; Shi, Junping; Zhang, Qin; Zhao, Yingren; Gao, Yufeng; Xin, Yongning; Zhu, Yueyong; Wu, Lixian; Mao, Xiaorong; Du, Jian; Shang, Jia; Sun, Weiwei; Xu, Jie; Yu, Zujiang; Nan, Yuemin; Sheng, Huiping; Li, Yue; Rao, Huiying; Yu, Chaohui; Cao, Haixiang; Chen, Bo; Li, Zhibin; Wu, Xiaoning; Tong, Xiaofei; You, Hong

Unstable Recompensation: An Intermediate Subtype in Patients With HBV-Related Decompensated Cirrhosis

不稳定代偿:乙型肝炎病毒相关失代偿性肝硬化患者的一种中间亚型

Xia, Shuai; He, Zhiying; Wu, Xiaoning; Hu, Zhongjie; Zhang, Chunqing; Hao, Yanqin; Yang, Yongfeng; Huang, Yan; Rao, Wei; Xu, Xiaoqian; Zhao, Xinyu; Zhou, Jialing; Sun, Yameng; Chen, Shuyan; Tang, Luqi; Ou, Xiaojuan; Zhao, Xinyan; Jia, Jidong; Wang, Bingqiong; You, Hong

Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment

血清蛋白质组学特征分析用于监测慢性乙型肝炎治疗患者肝纤维化的消退情况

Zhang, Mengyang; Chen, Shuyan; Wu, Xiaoning; Zhou, Jialing; Wang, Bingqiong; Meng, Tongtong; Hua, Rongxuan; Sun, Yameng; You, Hong; Chen, Wei

Hepatic stellate cell-derived microfibrillar-associated protein 2 prevents liver fibrosis by regulating extracellular matrix and inflammation.

肝星状细胞衍生的微纤维相关蛋白 2 通过调节细胞外基质和炎症来预防肝纤维化

Zhang Wen, Wu Wenyue, Zhang Ning, Li Hong, Sun Yameng, Ge Xiaodong, Han Hui, Chen Shuyan, Xu Anjian, Komakula Sai Santosh Babu, Wang Chao, Subramaniyam Nithyananthan, Han Qi, Yang Aiting, Yan Xuzhen, Nieto Natalia, You Hong, Chen Wei

Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies

基于三次肝活检结果,连续肝脏硬度测量和血清生物标志物并不能有效预测接受抗病毒治疗的慢性乙型肝炎患者的肝纤维化消退情况。

Zhang, Jiayi; Chen, Shuyan; Zhou, Jialing; Wang, Bingqiong; Wu, Xiaoning; Xu, Xiaoqian; Zhao, Xinyu; Kong, Yuanyuan; Ou, Xiaojuan; Sun, Yameng; You, Hong

The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis

PIR 分类在预测乙型肝炎合并晚期肝纤维化患者治疗期间的组织学和临床结果方面的应用价值

Chang, Xiujuan; Lv, Caihong; Wang, Bingqiong; Wang, Jing; Song, Zheng; An, Linjing; Chen, Shuyan; Chen, Yongping; Shang, Qinghua; Yu, Zujiang; Tan, Lin; Li, Qin; Liu, Huabao; Jiang, Li; Xiao, Guangming; Chen, Liang; Lu, Wei; Hu, Xiaoyu; Dong, Zheng; Chen, Yan; Sun, Yameng; Wang, Xiaodong; Li, Zhiqin; Chen, Da; You, Hong; Jia, Jidong; Yang, Yongping

Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK/TGF-β signaling

靶向血小板反应蛋白-2可通过抑制TLR4-FAK/TGF-β信号通路延缓肝纤维化

Zhang, Ning; Wu, Xiaoning; Zhang, Wen; Sun, Yameng; Yan, Xuzhen; Xu, Anjian; Han, Qi; Yang, Aiting; You, Hong; Chen, Wei

"Treat-all" Strategy for Patients with Chronic Hepatitis B Virus Infection in China: Are We There Yet?

中国对慢性乙型肝炎病毒感染患者采取“全民治疗”策略:我们达到目标了吗?

Zhang, Mengyang; Kong, Yuanyuan; Xu, Xiaoqian; Sun, Yameng; Jia, Jidong; You, Hong

The staging of nonalcoholic fatty liver disease fibrosis: A comparative study of MR elastography and the quantitative DCE-MRI exchange model

非酒精性脂肪性肝病纤维化的分期:磁共振弹性成像与定量动态对比增强磁共振成像交换模型的比较研究

Ren, Hao; Yang, Dawei; Xu, Hui; Tong, Xiaofei; Zhao, Xinyan; Wang, Qianyi; Sun, Yameng; Ou, Xiaojuan; Jia, Jidong; You, Hong; Wang, Zhenchang; Yang, Zhenghan

The Mechanism of Short-Circuit Oscillations in Automotive-Grade Multi-Chip Parallel Power Modules and an Effective Mitigation Approach

汽车级多芯片并联功率模块短路振荡机理及有效抑制方法

Ma, Kun; Sun, Yameng; Liu, Xun; Song, Yifan; Li, Xuehan; Shi, Huimin; Feng, Zheng; Zhang, Xiao; Zhou, Yang; Liu, Sheng